Portal de investigación
- Inicio
- Proyectos y Estudios
- ESTUDIO ABIERTO PARA EVALUAR LA SEGURIDAD, LA ACTIVIDAD ANTIVIRAL Y LA FARMACOCINÉTICA DEL TRATAMIENTO CON ANTIVIRALES DE ACCIÓN DIRECTA (AAD) EN COMBINACIÓN CON PEGINTERFERÓN ?-2A Y RIBAVIRINA (PEGIFN/RBV) EN SUJETOS CON INFECCIÓN CRÓNICA POR EL VIRUS DE LA HEPATITIS C (VHC) QUE HAN PRESENTADO FRACASO VIROLÓGICO EN UN ESTUDIO PREVIO DE ABBOTT SOBRE EL TRATAMIENTO COMBINADO CON AAD
ESTUDIO ABIERTO PARA EVALUAR LA SEGURIDAD, LA ACTIVIDAD ANTIVIRAL Y LA FARMACOCINÉTICA DEL TRATAMIENTO CON ANTIVIRALES DE ACCIÓN DIRECTA (AAD) EN COMBINACIÓN CON PEGINTERFERÓN ?-2A Y RIBAVIRINA (PEGIFN/RBV) EN SUJETOS CON INFECCIÓN CRÓNICA POR EL VIRUS DE LA HEPATITIS C (VHC) QUE HAN PRESENTADO FRACASO VIROLÓGICO EN UN ESTUDIO PREVIO DE ABBOTT SOBRE EL TRATAMIENTO COMBINADO CON AAD
Datos básicos
- Protocolo:
- M13-101
- EUDRACT:
- 2011-005393-32
- NCT:
- Centro:
- HOSPITAL UNIVERSITARI I POLITÈCNIC LA FE
- Año de incio:
- 2012
- Año de finalización:
- 2015
Objetivos del proyecto
Observaciones: Estado Comité: CENTRO CERRADO
Documentos
- No hay documentos
Participantes
Financiadores - Promotores
Resultados del Ensayo Clínico
[Farewell open letter to SEFH members].
Editorial Material. 10.7399/fh.2015.39.6.10128. 2015
[Hepatitis C treatment in special patient groups].
Berenguer, Marina; (...); Castellano, Gregorio
Article. 2014
Acute cellular rejection versus recurrent hepatitis C after liver transplantation: Clinical and pathological features driving a rational diagnostic approach
de la Peña-Moral JM; (...); Parrilla P
Article. 10.1111/hepr.12369. 2015
ADVERSE EFFECTS OF TRIPLE THERAPY WITH BOCEPREVIR (BOC) AND TELAPREVIR (TVR) IN CLINICAL PRACTICE IN PATIENTS WITH ADVANCED HEPATIC FIBROSIS
Salmeron, J.; (...); Prieto, M.
Article. 10.1016/S0168-8278(14)61356-8. 2014
Alterations in carbohydrate metabolism in cirrhotic patients before and after liver transplant
Ramos-Prol A; (...); Merino-Torres JF
Article. 10.1016/j.diabres.2015.10.002. 2015
Altered underlying tubular function in HBV monoinfected patients receiving nucleos(t)ide analogs in a real-world setting: MENTE Study
Rodriguez Novoa, Sonia; (...); Castro, Angeles
Article. 2014
ANABOLIC ANDROGENIC STEROIDS (AAS) ILLICIT USE IS A RAPIDLY GROWING CAUSE OF DRUG-INDUCED LIVER INJURY (DILI): A PROSPECTIVE SERIES FROM THE SPANISH-LATIN-AMERICAN DILI REGISTRY
Medina-Caliz, I.; (...); Andrade, R. J.
Article. 10.1016/S0168-8278(14)60472-4. 2014
Analisis de las causas de suspension de tratamiento con triple terapia antiviral en pacientes con hepatitis C.
Ruiz Ramos J; (...); Poveda Andrés JL
Abstract of Published Item. 10.7399/fh.2014.38.3.1171. 2014
Anidulafungin-Induced Alopecia
Ruiz-Ramos J; (...); Poveda-Andrés JL
Article. 10.1177/1060028014524534. 2014
Association of SNPs with the efficacy and safety of immunosuppressant therapy after heart transplantation
Sánchez-Lázaro I; (...); Aliño SF
Article. 10.2217/pgs.15.39. 2015
Avances en el tratamiento de la hepatitis C.
Vinaixa C, Aguilera V, Berenguer M
Abstract of Published Item. 10.1016/j.medcli.2013.01.041. 2013
Beyond cure: preventing and managing the complications of end-stage liver disease
Berenguer M; (...); Puoti M
Review. 10.1097/COH.0000000000000184. 2015
Biosimilares: viejas polemicas con nuevos argumentos.
Poveda-Andrés JL, Bosó-Ribelles V
Editorial Material. 10.7399/fh.2015.39.3.8978. 2015
Calidad y Legibilidad de la Hoja de Informacion al Paciente en Estudios con Analisis Farmacogenetico.
Ruiz Ramos J; (...); Poveda Andrés JL
Article. 2015
Clinical evaluation of rituximab treatment for neuromyelitis optica
Fernández-Megía MJ; (...); Poveda-Andrés JL
Article. 10.1016/j.nrl.2014.09.001. 2015
Clinical experiences with cannabinoids in spasticity management in multiple sclerosis
Lorente Fernández L; (...); Casanova-Estruch B
Article. 10.1016/j.nrl.2013.06.014. 2014
Clinical features and risk factors associated with Non-alcoholic steatohepatitis (NASH) in Spain. On behalf of HEPAmet Registry
Gallego-Duran, Rocio; (...); Romero-Gomez, Manuel
Article. 2015
Comparison of results of combined liver-kidney transplantation vs. isolated liver transplantation.
Aguilera V; (...); Mir J
Article. 10.1016/S1665-2681(19)31366-3. 2013
Comparison of two non-contemporaneous HCV-liver transplant cohorts: strategies to improve the efficacy of antiviral therapy.
Berenguer M; (...); Prieto M
Article. 10.1016/j.jhep.2011.12.031. 2012
Computational models of liver fibrosis progression for hepatitis C virus chronic infection
Lara J; (...); Khudyakov YE
Article. 10.1186/1471-2105-15-S8-S5. 2014
Control of blood pressure in liver transplant recipients.
Martínez-Saldivar B; (...); Rimola A
Article. 10.1097/TP.0b013e31824cd5e6. 2012
Control of Diabetes Mellitus in Liver Transplant Recipients
Ramos-Prol, Agustin; (...); Francisco Merino-Torres, Juan
Article. 2014
Cost-effectiveness of methoxy polyethylene glycolepoetin beta versus conventional epoetin in the treatment of anaemia secondary to chronic kidney disease in clinical practice
Lorente-Fernandez, L; (...); Poveda-Andres, JL
Article. 10.1136/ejhpharm-2013-000426. 2015
CHARACTERIZATION OF HBsAg LOSS IN PATIENTS WITH CHRONIC HEPATITIS B (CHB) TREATED WITH NUCLEOS/TIDE ANALOGS (NUCS): A RETROSPECTIVE MULTICENTER STUDY (HEBESAS)
Suarez, E.; (...); Fuentes, J.
Article. 10.1016/S0168-8278(15)30854-0. 2015
Chronic kidney disease after liver transplantation: pretransplantation risk factors and predictors during follow-up.
Giusto M; (...); Merli M
Article. 10.1097/TP.0b013e3182884890. 2013
Distinct phenotype of hepatotoxicity associated with illicit use of anabolic androgenic steroids
Robles-Diaz M; (...); SLatinDILI Network
Article. 10.1111/apt.13023. 2015
DISTINGUISHING DRUG INDUCED AUTOIMMUNE HEPATITIS FROM IDIOPATIC AUTOIMMUNE HEPATITIS
Ortega-Alonso, A.; (...); Lucena, M. I.
Article. 10.1016/S0168-8278(15)31294-0. 2015
Documento de consenso de la AEEH sobre el tratamiento de la infección por el virus de la hepatitis B (2012).
Buti M; (...); Esteban R
Article. 10.1016/j.gastrohep.2012.04.006. 2012
Dose banding aplicado a la elaboracion de antineoplasicos: una revision narrativa de la literatura.
Pérez Huertas P; (...); Poveda Andrés JL
Article. 10.7399/fh.2015.39.4.8839. 2015
Drug Interaction Between Oral Cyclosporine Modified and Iron
Domingo-Chiva, E; (...); Poveda-Andres, JL
Article. 10.1177/1060028013514734. 2014
ECONOMIC IMPACT LINKED TO THE REDUCTION OF EXACERBATIONS WHEN A TREATMENT REGIME WITH INHALED ANTIBIOTICS IS SWITCHED TO AZTREONAM LYSINE IN PATIENTS WITH CYSTIC FIBROSIS AND CHRONIC PULMONARY INFECTION CAUSED BY PSEUDOMONAS AERUGINOSA
Sole A; (...); Casado MA
Meeting Abstract. 10.1016/j.jval.2014.08.1659. 2014
EFFECT OF CYP3A5 GENOTYPE ON TACROLIMUS DOSE REQUIREMENT, NEPHROTOXICITY AND ACUTE REJECTION IN KIDNEY TRANSPLANTATION: A SYSTEMATIC REVIEW AND META-ANALYSIS OF OBSERVATIONAL STUDIES
Rojas, L.; (...); Alino, S. F.
Article. 2013
Effect of CYP3A5*3 on kidney transplant recipients treated with tacrolimus: a systematic review and meta-analysis of observational studies
Rojas L; (...); Aliño SF
Article. 10.1038/tpj.2014.38. 2015
EFFECTIVENESS OF TRIPLE THERAPY WITH BOCEPREVIR OR TELAPREVIR IN A MULTICENTRE CLINICAL PRACTICE COHORT OF HCV TREATMENT-EXPERIENCED PATIENTS WITH ADVANCED HEPATIC FIBROSIS. SVR-12W AFTER TREATMENT
FERNANDEZ, C.; (...); Salmeron, J.
Article. 10.1016/S0168-8278(14)61360-X. 2014
EFFECTS OF POLYMORPHIMS OF CYP3A5 AND ABCB1 GENES ON CHRONIC NEPHROPATHY: COHORT STUDY
Rojas, L.; (...); Alino, S. F.
Article. 2013
Efficacy and safety of entecavir in clinical practice in treatment-naive Caucasian chronic hepatitis B patients (vol 24, pg 535, 2012)
Buti, Maria; (...); Rodriguez, Manuel
Article. 10.1097/MEG.0b013e328356123a. 2012
Efficacy of retreatment of HCV infection after liver transplantation (lt): role of aggressive approach
Berenguer, Marina; (...); Samuel, Didier
Article. 2012
Efficacy of the retreatment of hepatitis C virus infections after liver transplantation: Role of an aggressive approach
Berenguer, Marina; (...); Samuel, Didier
Article. 2013
Efficacy of the retreatment of hepatitis C virus infections after liver transplantation: role of an aggressive approach.
Berenguer M; (...); Samuel D
Article. 10.1002/lt.23555. 2013
Entecavir has high efficacy and safety in white patients with chronic hepatitis B and comorbidities
Buti M; (...); Gila A
Article. 10.1097/MEG.0000000000000195. 2015
Estrategias para evitar la recidiva viral B despues del trasplante hepatico.
Abstract of Published Item. 10.1016/S0210-5705(14)70067-6. 2014
Estudio de utilizacion de boceprevir y telaprevir para el tratamiento de la hepatitis C cronica.
Marrero-Álvarez P; (...); Poveda-Andrés JL
Abstract of Published Item. 10.7399/FH.2014.38.1.1128. 2014
Experience in the management of immunosuppressant treatment with hepatitis C virus protease inhibitors
Ruiz Ramos J; (...); Poveda Andrés JL
Article. 10.1016/j.gastrohep.2014.05.004. 2014
EXPERTS CONSENSUS ON THE FUTURE OF RARE DISEASES CARE AND ORPHAN DRUGS ACCESS IN SPAIN: A DELPHI STUDY
Paz S; (...); Urcelay J
Meeting Abstract. 10.1016/j.jval.2015.09.2016. 2015
FIRST REAL CLINICAL PRACTICE DATA IN SPAIN ON SOFOSBUVIR, SIMEPREVIR AND DACLATASVIR IN POST-TRANSPLANT HCV RECURRENCE: THE HepatiC REGISTRY EXPERIENCE
Prieto, M.; (...); Forns, X.
Article. 10.1016/S0168-8278(15)30988-0. 2015
Framingham score, renal dysfunction, and cardiovascular risk in liver transplant patients
Di Maira, Tommaso; (...); Berenguer, Marina
Article. 10.1002/lt.24128. 2015
Genotype and Allele Frequencies of Drug-Metabolizing Enzymes and Drug Transporter Genes Affecting Immunosuppressants in the Spanish White Population
Bosó V; (...); Aliño SF
Article. 10.1097/FTD.0b013e3182a94e65. 2014
Haemophagocytic syndrome in a liver transplant patient during treatment with Telaprevir.
Rodríguez-Medina B; (...); Berenguer M
Article. 10.1016/S1665-2681(19)31305-5. 2013
HCV-Induced Immune Responses Influence the Development of Operational Tolerance After Liver Transplantation in Humans
Bohne, Felix; (...); Sanchez-Fueyo, Alberto
Article. 10.1126/scitranslmed.3008793. 2014
Hepatitis B virus quasispecies evolution after liver transplantation in patients under long-term lamivudine prophylaxis with or without hepatitis B immune globulin
Buti M; (...); Esteban R
Article. 10.1111/tid.12360. 2015
Hepatitis B virus recurrence after liver transplantation and evolution of viral quasispecies
Buti, Maria; (...); Rodriguez-Frias, Francisco
Article. 2014
Hepatitis C Virus Recurrence After Liver Transplantation: How to Treat and When
Article. 10.1016/j.transproceed.2014.09.177. 2014
Hepatitis C Virus-Associated Cholestatic Hepatitis: We Cannot Seem to Agree on Diagnostic Criteria
Berenguer, Marina, McCaughan, Geoffrey
Discussion. 2013
Hepatitis C virus-associated cholestatic hepatitis: we cannot seem to agree on diagnostic criteria.
Berenguer M, McCaughan G
Editorial Material. 10.1002/lt.23580. 2013
High efficacy and safety of triple therapy in HCV genotype 1 and moderate fibrosis: a multicenter study of clinical practice in Spain
Crespo J; (...); Hernández-Guerra M
Article. 10.1016/S1665-2681(19)31169-X. 2015
IMPACT OF ANTICOAGULANT THERAPY ON UPPER GASTROINTESTINAL BLEEDING (UGI) IN PATIENTS WITH LIVER CIRRHOSIS. RESULTS FROM A RETROSPECTIVE MULTICENTRIC CASE-CONTROL STUDY
Cerini, F.; (...); Garcia-Pagan, J. C.
Article. 10.1016/S0168-8278(14)60019-2. 2014
Impact of anticoagulation on upper-gastrointestinal bleeding in cirrhosis. A retrospective multicenter study
Cerini F; (...); Garcia-Pagán JC
Article. 10.1002/hep.27783. 2015
Impact of Single Nucleotide Polymorphisms (SNPs) on Immunosuppressive Therapy in Lung Transplantation
Ruiz J; (...); Aliño SF
Article. 10.3390/ijms160920168. 2015
IMPROVED OUTCOME AFTER ANTI-HCV THERAPY IS LESS MARKED WHEN THERAPY IS STARTED AT ADVANCED STAGES OF FIBROSIS
Aguilera, V.; (...); Berenguer, M.
Article. 2012
Improved Renal Function in Liver Transplant Recipients Treated for Hepatitis C Virus With a Sustained Virological Response and Mild Chronic Kidney Disease
Blé M; (...); Berenguer M
Article. 10.1002/lt.23756. 2014
Incompatibility of undiluted busulfan injection with a needle-free valve
Cueto-Sola, M; (...); Poveda-Andres, JL
Letter. 10.2146/ajhp140111. 2014
Increased hospital stay and allograft dysfunction in renal transplant recipients with Cyp2c19 AA variant in SNP rs4244285.
Bosó V; (...); Aliño SF
Article. 10.1124/dmd.112.047977. 2013
Influence of ABCB1 polymorphisms upon the effectiveness of standard treatment for acute myeloid leukemia: A systematic review and meta-analysis of observational studies
Megías-Vericat JE; (...); Aliño SF
Review. 10.1038/tpj.2014.80. 2015
Lack of effect of CMV reactivation in the outcome of HCV-infected liver transplant(LT)patients
Aguilera, Victoria; (...); Berenguer, Marina
Article. 2015
Lead-in period and week 8 as predictive tools for response to boceprevir therapy: a retrospective study of Spanish real clinical practice
Crespo J; (...); Calleja JL
Article. 10.1016/j.gastrohep.2015.04.002. 2015
Liver transplantation for unresectable hepatocellular carcinoma in normal livers
Mergental, Hynek; (...); Porte, Robert J.
Article. 2012
Long-Term Complications After Liver Transplantation: Results at 15 Years After Transplantation
Berenguer, Marina; (...); Prieto, Martn
Article. 2015
Long-term outcome of "long-term liver transplant survivors"
Berenguer, Marina; (...); Prieto, Martin
Article. 2012
LONG-TERM OUTCOME OF LIVER TRANSPLANTATION FOR HEPATITIS B WITH ANTI-HBC POSITIVE GRAFTS
Garcia-Eliz, M.; (...); Prieto, M.
Article. 10.1016/S0168-8278(12)60208-6. 2012
Long-Term Outcome of Liver Transplantation for Hepatitis B with Anti-HBc Positive Grafts.
Garcia-Eliz, Maria; (...); Prieto, Martin
Article. 2012
Long-term outcome of 'long-term liver transplant survivors'.
Rubín A; (...); Berenguer M
Article. 10.1111/tri.12118. 2013
Management of anemia induced by triple therapy in patients with chronic hepatitis C: challenges, opportunities and recommendations.
Romero-Gómez M; (...); Calleja JL
Article. 10.1016/j.jhep.2013.07.014. 2013
Management of HCV in the liver transplant setting
Review. 10.1016/j.clinre.2015.05.004. 2015
Meta-analysis and systematic review of the effect of the donor and recipient CYP3A5 6986A>G genotype on tacrolimus dose requirements in liver transplantation.
Rojas LE; (...); Aliño SF
Article. 10.1097/FPC.0b013e3283642fb3. 2013
N. VICTOR JIMENEZ TORRES (1942-2015) IN MEMORIAM
Climente Martí M, Poveda Andrés JL, Culebras J
Biographical-Item. 10.3305/nh.2015.32.4.9704. 2015
New concepts and best practices for management of pre- and post-transplantation cancer.
Campistol JM; (...); Ussetti P
Article. 10.1016/j.trre.2012.07.001. 2012
Ombitasvir plus paritaprevir plus ritonavir with or without ribavirin in treatment-naive and treatment-experienced patients with genotype 4 chronic hepatitis C virus infection (PEARL-I): a randomised, open-label trial
Hézode C; (...); Pol S
Article. 10.1016/S0140-6736(15)60159-3. 2015
Ombitasvir plus paritaprevir plus ritonavir with or without ribavirin in treatment-naive and treatment-experienced patients with genotype 4 chronic hepatitis C virus infection (PEARL-I): a randomised, open-label trial
Hezode, Christophe; (...); Pol, Stanislas
Article. 2015
Ombitasvir/Paritaprevir/r and Dasabuvir with or without Ribavirin for HCV Patients with Post-Transplant Recurrence
Mantry, Parvez S.; (...); Forns, Xavier
Article. 2015
Ombitasvir/paritaprevir/r, dasabuvir and ribavirin for cirrhotic HCV patients with thrombocytopaenia and hypoalbuminaemia
Forns X; (...); Everson G
Article. 10.1111/liv.12931. 2015
ON-TREATMENT VIROLOGIC RESPONSE AND TOLERABILITY OF SIMEPREVIR, DACLATASVIR AND RIBAVIRIN IN PATIENTS WITH RECURRENT HEPATITIS C VIRUS GENOTYPE 1b INFECTION AFTER ORTHOTOPIC LIVER TRANSPLANTATION (OLT): INTERIM DATA FROM THE PHASE II SATURN STUDY
Forns, X.; (...); Witek, J.
Article. 10.1016/S0168-8278(15)30011-8. 2015
Outcomes in liver transplantation: Does sex matter?
Sarkar M; (...); Berenguer M
Review. 10.1016/j.jhep.2014.11.023. 2015
Overcoming drug resistance in HSV, CMV, HBV and HCV infection
López-Labrador FX, Berenguer M, Navarro D
Review. 10.2217/fmb.15.74. 2015
Paclitaxel and carboplatin treatment for advanced ovarian cancer during pregnancy.
Ruiz Ramos J; (...); Poveda JL
Article. 10.1159/000360691. 2013
Pegylated interferon plus ribavirin in HIV-infected patients with recurrent hepatitis C after liver transplantation: A prospective cohort study
Castells L; (...); FIPSE LT-HIV Investigators
Article. 10.1016/j.jhep.2014.07.034. 2015
Phenotypic and genotypic characterization of drug-induced liver injury (DILI) with autoimmune features
Stephens, C.; (...); Andrade, Raul J.
Article. 2015
PREDICTIVE FACTORS OF SURVIVAL AND PROGNOSTIC SCORE VALIDATION IN LIVER RETRANSPLANTATION FOR SEVERE HEPATITIS C RECURRENCE: THE IMPORTANCE OF HCV THERAPY BEFORE AND AFTER RETRANSPLANTATION
Song, A. T. W.; (...); Samuel, D.
Article. 10.1016/S0168-8278(13)60186-5. 2013
Pre-Immunosuppressant Hepatitis B Virus Screening Practices Among Various Medical Specialities (HEBRA Project): Results of a Survey from 19 Spanish Hospitals
Garcia-Bengoechea, Manuel; (...); Esteban, Rafael
Article. 2012
Profiles and clinical management of hepatitis C patients in Spain: disHCovery study
Buti M; (...); Esteban R
Article. 2015
Prognostic Impact of Anthracycline Metabolism Gene Polymorphisms in Newly Diagnosed Acute Myeloid Leukemia Adults
Eduardo Megias, Juan; (...); Angel Sanz, Miguel
Article. 2014
Prognostic Impact of Cytarabine Pathway Gene Polymorphisms in Acute Myeloid Leukemia Adults Undergoing Induction Chemotherapy
Eduardo Megias, Juan; (...); Angel Sanz, Miguel
Article. 2014
PROGNOSTIC IMPACT OF TRANSPORTER GENE POLYMORPHISMS IN NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA ADULTS
Megias Vericat, J. E.; (...); Sanz, M. A.
Article. 2015
Progress in hepatitis C treatment
Vinaixa, Carmen, Aguilera, Victoria, Berenguer, Marina
Review. 2013
Progression of liver fibrosis in post-transplant hepatitis C: mechanisms, assessment and treatment.
Berenguer M, Schuppan D
Article. 10.1016/j.jhep.2012.12.014. 2013
Protease inhibitors impair renal function in HCV-infected immunocompetent patients
Fernandez-Carrillo, Carlos; (...); Luis Calleja, Jose
Meeting Abstract. 2014
Rabbit anti-thymocyte globulin in liver transplantation: all that glitters is not gold, but 1000 patients are so many to dazzle.
Berenguer M, Pons JA
Editorial Material. 10.1002/lt.23432. 2012
Renal function improvement in liver transplant recipients after early everolimus conversion: A clinical practice cohort study in Spain
Bilbao I; (...); Guilera M
Article. 10.1002/lt.24172. 2015
Renal Transplantation Recipients with AA Genotype in SNP rs4244285 of CYP2C19 Show An Increase in Hospital Stay Duration and Allograft Dysfunction Probably Due to Increased Tacrolimus Levels Caused by Interaction with Omeprazol
Boso, V; (...); Alino, S. F.
Article. 10.1097/00007890-201211271-01757. 2012
Reply to: "Renal impairment and anemia during triple therapy"
Romero-Gómez M; (...); Calleja JL
Letter. 10.1016/j.jhep.2014.01.007. 2014
Response to different therapeutic approaches in Wilson disease. A long-term follow up study.
Rodríguez B, Burguera J, Berenguer M
Article. 10.1016/S1665-2681(19)31417-6. 2012
Selective ophthalmic intra-arterial melphalan therapy for advanced retinoblastoma: implementation and outcomes of a new chemotherapy protocol.
Valero García S; (...); Poveda Andrés JL
Article. 10.1177/1078155212457964. 2013
Sexual Dysfunction in Cirrhotic Patients Awaiting Liver Transplantation.
Rodriguez-Medina, Beatriz; (...); Berenguer, Marina
Article. 2013
Single Nucleotide Polymorphisms, SNPs, Associated With the Efficacy and Security of Immunosuppressive Treatment in Heart Transplantation
Sanchez-Lazaro, I.; (...); Salvador-Sanz, A.
Article. 10.1016/j.healun.2014.01.392. 2014
SNPs and taxane toxicity in breast cancer patients
Bosó V; (...); Aliño SF
Article. 10.2217/PGS.14.127. 2014
Sofosbuvir Compassionate Use Program for Patients With Severe Recurrent Hepatitis C After Liver Transplantation
Forns X; (...); Habersetzer F
Article. 10.1002/hep.27681. 2015
Spanish Consensus on the Prevention and Treatment of Pseudomonas aeruginosa Bronchial Infections in Cystic Fibrosis Patients
Cantón R; (...); Solé A
Article. 10.1016/j.arbres.2014.09.021. 2015
Spanish society of liver transplantation (SETH) consensus recommendations on hepatitis C virus and liver transplantation.
Berenguer M; (...); Ignacio Herrero J
Article. 10.1111/j.1478-3231.2011.02731.x. 2012
Study on the Linezolid Prescription According to the Approval of Indication in a University Hospital
Pérez-Cebrián M; (...); Llopis-González A
Article. 2015
TENOFOVIR FOR THE PROPHYLAXIS OF HBV REACTIVATION IN ANTI-HBC-POSITIVE PATIENTS WITH HEMATOLOGIC MALIGNANCIES TREATED WITH RITUXIMAB: PRELIMINARY RESULTS OF A RANDOMIZED STUDY (PREBLIN STUDY)
Buti, M.; (...); Esteban, R.
Article. 10.1016/S0168-8278(14)61200-9. 2014
TENOFOVIR MONOTHERAPY VERSUS LAMIVUDINE PLUS ADEFOVIR IN LAMIVUDINE-FAILURE PATIENTS RESCUED WITH LAMIVUDINE PLUS ADEFOVIR COMBINATION: INTERIM ANALYSIS OF THE TENOSIMP-B CLINICAL TRIAL
Jorquera, F.; (...); Rodriguez, M.
Article. 10.1016/S0168-8278(14)61201-0. 2014
The impact of the prevention strategies on the indirect effects of CMV infection in solid organ transplant recipients
Roman A; (...); Ussetti P
Article. 10.1016/j.trre.2014.01.001. 2014
Trans-arterial chemoembolization with doxorubicin-eluting particles versus conventional trans-arterial chemoembolization in unresectable hepatocellular carcinoma: A study of effectiveness, safety and costs.
Megías Vericat JE; (...); Poveda Andrés JL
Article. 10.1016/j.rx.2015.01.008. 2015
Trasplante hepático: inmunosupresión personalizada en pacientes con hepatitis C y carcinoma hepatocelular.
Abstract of Published Item. 10.1016/j.gastrohep.2012.03.006. 2013
Tratamiento de la hepatitis C en grupos de pacientes especiales.
Berenguer M; (...); Castellano G
Abstract of Published Item. 10.1016/S0210-5705(15)30004-2. 2014
Treatment adherence and other patient-reported outcomes as cost determinants in multiple sclerosis: a review of the literature
Lizan, L; (...); Polanco, C
Review. 10.2147/PPA.S67253. 2014
TREATMENT-NAIVE STABLE LIVER TRANSPLANT PATIENTS WITH GENOTYPE-1 HCV INFECTION: PHARMACOKINETIC RESULTS OF ADJUSTED DOSING WITH TACROLIMUS OR CYCLOSPORINE IN THE TELAPREVIR REPLACE STUDY
Forns, X.; (...); Bertelsen, K.
Article. 2014
Triple Therapy for HCV Cirrhosis in Liver Transplant Candidates. High Rate of Prevention of HCV Recurrence after Liver Transplantation (LT) in Well Selected Patients
Maria Braithwaite, Ana; (...); Berenguer, Marina
Article. 2014
T-tube or no T-tube in cadaveric orthotopic liver transplantation: the eternal dilemma: results of a prospective and randomized clinical trial.
López-Andújar R; (...); De Juan Burgueño M
Article. 10.1097/SLA.0b013e318286e0a0. 2013
Use of artificial intelligence as an innovative donor-recipient matching model for liver transplantation: Results from a multicenter Spanish study
Briceño J; (...); de la Mata M
Article. 10.1016/j.jhep.2014.05.039. 2014
Use of Hy's Law and a New Composite Algorithm to Predict Acute Liver Failure in Patients With Drug-Induced Liver Injury
Robles-Diaz M; (...); Safer and Faster Evidence-based Translation Consortium
Article. 10.1053/j.gastro.2014.03.050. 2014